|
ASB3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.463400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.516600E-01 |
| Normal-vs-Stage2 |
3.255000E-01 |
| Normal-vs-Stage3 |
9.301800E-01 |
| Normal-vs-Stage4 |
6.021600E-01 |
| Stage1-vs-Stage2 |
9.032000E-02 |
| Stage1-vs-Stage3 |
5.381200E-01 |
| Stage1-vs-Stage4 |
4.880000E-01 |
| Stage2-vs-Stage3 |
3.430600E-01 |
| Stage2-vs-Stage4 |
8.329800E-01 |
| Stage3-vs-Stage4 |
5.894800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.921400E-01 |
| Normal-vs-AfricanAmerican |
7.132000E-01 |
| Normal-vs-Asian |
2.120000E-01 |
| Caucasian-vs-AfricanAmerican |
6.709400E-01 |
| Caucasian-vs-Asian |
3.511200E-01 |
| AfricanAmerican-vs-Asian |
2.600400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.790800E-01 |
| Normal-vs-Female |
2.700800E-01 |
| Male-vs-Female |
4.413500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.421200E-01 |
| Normal-vs-Extreme_Weight |
2.956000E-01 |
| Normal-vs-Obese |
6.761000E-01 |
| Normal-vs-Extreme_Obese |
9.664800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.003000E-01 |
| Normal_Weight-vs-Obese |
4.228200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.832600E-01 |
| Extreme_Weight-vs-Obese |
4.638200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.514400E-01 |
| Obese-vs-Extreme_Obese |
8.296200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.165600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.082400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.834600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.110370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.048600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.352200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.973800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.543800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.031640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.281800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.824200E-01 |
| Normal-VS-Type2 PRCC |
7.019900E-02 |
| Normal-VS-KIRP CIMP |
3.625200E-01 |
| Normal-VS-Unclassified PRCC |
3.378600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.855900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.097200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.006400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.366020E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.108500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.277200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.227600E-01 |
| Normal-vs-N1 |
3.126400E-01 |
| Normal-vs-N2 |
6.789800E-01 |
| N0-vs-N1 |
1.255040E-01 |
| N0-vs-N2 |
3.603000E-01 |
| N1-vs-N2 |
5.733800E-01 |
|
|
